In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 4.24 below Bio Green Med Solution Inc average.

Within Major Pharmaceutical Preparations industry 175 other companies have achieved higher Quick Ratio than Bio Green Med Solution Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 655 to 761.

Explain Quick Ratio?
How much Cash & cash equivalents BGMS�s has?
What are BGMS�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BGMS/financial-strength

https://api.csimarket.com/api/v1/companies/BGMS/fundamentals

https://api.csimarket.com/api/v1/companies/BGMS/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

BGMS Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	-18.66 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-10.01 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	4.24	Subscribe	Subscribe	Subscribe	Subscribe
BGMS's Total Ranking	# 761	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	17.77 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	-8.87 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 176
Healthcare Sector	# 284
Overall Market	# 761

Quick Ratio Statistics
High	Average	Low
17.24	4.83	0.34
(Mar 31 2021)		(Mar 31 2024)

Financial Statements
Bio Green Med Solution Inc 's Current Liabilities	$ 1 Millions	Visit BGMS's Balance sheet
Bio Green Med Solution Inc 's Cash & cash equivalent	$ 3 Millions	Visit BGMS's Balance sheet
Source of BGMS's Sales		Visit BGMS's Sales by Geography

Cumulative Bio Green Med Solution Inc 's Quick Ratio

BGMS's Quick Ratio for the trailling 12 Months

BGMS Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-58.18 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-4.16 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	3.88	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 3664	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	-4.89 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-2.65 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to BGMS Financial Strength Comparisons >> Go to Compare BGMS Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Bio Green Med Solution Inc 's average Cash & cash equivalent, this led to increase in in Bio Green Med Solution Inc 's Quick Ratio to 3.88, Quick Ratio remained below BGMS average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 426 other companies have achieved higher Quick Ratio than Bio Green Med Solution Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2725 to 3664.

Explain Quick Ratio?
How much Cash & cash equivalents BGMS�s has?
What are BGMS�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 427
Healthcare Sector	# 869
Within the Market	# 3664

trailing twelve months Quick Ratio Statistics
High	Average	Low
15.29	4.63	0.5
(Mar 31 2021)		(Sep 30 2024)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Major Pharmaceutical Preparations Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Structure Therapeutics Inc	11.62	$ 1,244.661 Millions	$ 107.104 Millions
Kairos Pharma Ltd	11.60	$ 5.741 Millions	$ 0.495 Millions
Immunome Inc	11.27	$ 461.582 Millions	$ 40.966 Millions
Korro Bio Inc	11.06	$ 165.015 Millions	$ 14.923 Millions
Curanex Pharmaceuticals Inc	11.02	$ 1.580 Millions	$ 0.143 Millions
Xenon Pharmaceuticals Inc	10.99	$ 950.798 Millions	$ 86.487 Millions
Newamsterdam Pharma Company N v	10.99	$ 628.242 Millions	$ 57.154 Millions
Vtv Therapeutics Inc	10.99	$ 77.164 Millions	$ 7.024 Millions
Abcellera Biologics Inc	10.85	$ 764.424 Millions	$ 70.473 Millions
Cogent Biosciences Inc	10.82	$ 791.134 Millions	$ 73.118 Millions
Bicycle Therapeutics Plc	10.57	$ 469.928 Millions	$ 44.459 Millions
Lipocine Inc	10.55	$ 21.455 Millions	$ 2.034 Millions
Cyclerion Therapeutics Inc	10.32	$ 456.221 Millions	$ 44.197 Millions
Lexicon Pharmaceuticals Inc	10.31	$ 183.203 Millions	$ 17.773 Millions
Adicet Bio Inc	10.28	$ 174.779 Millions	$ 16.996 Millions
An2 Therapeutics Inc	10.26	$ 64.400 Millions	$ 6.275 Millions
Pmv Pharmaceuticals Inc	10.15	$ 108.515 Millions	$ 10.689 Millions
Gri Bio Inc	9.94	$ 9.472 Millions	$ 0.953 Millions
Nuvectis Pharma inc	9.91	$ 140.707 Millions	$ 14.193 Millions
Renovorx Inc	9.76	$ 20.404 Millions	$ 2.091 Millions
Aprea Therapeutics Inc	9.52	$ 37.846 Millions	$ 3.975 Millions
Rezolute Inc	9.51	$ 89.999 Millions	$ 9.463 Millions
Atrium Therapeutics Inc	9.42	$ 232.421 Millions	$ 24.663 Millions
Opus Genetics Inc	9.05	$ 88.974 Millions	$ 9.832 Millions
Ibio inc	8.94	$ 76.654 Millions	$ 8.574 Millions
Enveric Biosciences Inc	8.71	$ 5.613 Millions	$ 0.644 Millions
Ideaya Biosciences Inc	8.70	$ 838.541 Millions	$ 96.405 Millions
First Tracks Biotherapeutics Inc	8.60	$ 155.627 Millions	$ 18.090 Millions
Pepgen Inc	8.48	$ 104.805 Millions	$ 12.361 Millions
Medicinova Inc	8.47	$ 29.256 Millions	$ 3.456 Millions

Date modified: 2026-11-13T21:11:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.